SELLAS Life Sciences Group, Inc.
(NASDAQ : SLS)

( )
SLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 2.91%69.000.0%$1792.09m
GILDGilead Sciences, Inc. -0.22%73.341.0%$1310.05m
AMGNAmgen, Inc. 0.73%226.431.3%$654.36m
REGNRegeneron Pharmaceuticals, Inc. 1.59%569.912.5%$571.28m
NVAXNovavax, Inc. -7.91%46.11102.0%$561.17m
VRTXVertex Pharmaceuticals, Inc. 0.12%284.961.9%$530.07m
BIIBBiogen, Inc. 0.02%304.531.6%$421.31m
ILMNIllumina, Inc. 1.51%354.703.5%$346.79m
SRNESorrento Therapeutics, Inc. 0.80%5.071.8%$295.47m
SGENSeattle Genetics, Inc. 1.02%155.776.1%$235.46m
ALXNAlexion Pharmaceuticals, Inc. 0.36%101.502.0%$221.68m
MGNXMacroGenics, Inc. 0.84%25.376.2%$199.40m
CODXCo-Diagnostics, Inc. 2.94%18.550.0%$198.21m
AAgilent Technologies, Inc. 5.24%84.981.6%$189.94m
BMRNBioMarin Pharmaceutical, Inc. 2.80%97.514.3%$148.95m

Company Profile

SELLAS Life Sciences Group, Inc. engages in the development and commercialization of immunotherapeutics for cancer indications. Its product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.